Y. T. Tai and C. V. Tong, “The Perilous PPI: Proton Pump Inhibitor as a Cause of Clinically Significant Hypomagnesaemia”, J ASEAN Fed Endocr Soc, vol. 35, no. 1, pp. 109–113, Apr. 2020.